Sanara MedTech Inc. Reports Second Quarter 2024 Results

FORT WORTH, TX, August 12, 2024 (GLOBE NEWSWIRE) — Sanara MedTech Inc. Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), based in Fort Worth, Texas, is a medical technology company focused on the development and commercialization of transformative technologies to improve clinical outcomes and reduce healthcare spending in the surgical, chronic wound and skin care markets. Today, the Company announced its strategic, operational and financial results for the quarter ended June 30, 2024.

Ron Nixon, CEO of Sanara, said: “The second quarter of 2024 was Sanara’s eleventh consecutive quarter of record sales. Our surgical team continues to generate strong sales, driven by the efficacy and value proposition of our products. All of our functional areas, including clinical, research and development, customer service, marketing and finance, continue to do an excellent job supporting our growth strategy. In addition to our financial success this quarter, we have also taken steps to strengthen our senior management team.”